DS
SMTI icon

David Shaw’s Sanara MedTech SMTI Stock Holding History

David Shaw’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$386K Buy
16,370
+47
+0.3% +$972 ﹤0.01% 4295
2026
Q1 		$280K Buy
16,323
+2,020
+14% +$41.6K ﹤0.01% 4104
2025
Q4 		$334K Buy
+14,303
New +$369K ﹤0.01% 4101

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

David Shaw's SMTI Position: Q2 2026 in Review

David Shaw increased its Sanara MedTech (SMTI) stake by 0.29% in Q2 2026, buying an estimated $972 and bringing the position to 16,370 shares worth $386K. The position accounts for ﹤0.01% of the portfolio, ranked #4295.

David Shaw first reported a position in SMTI in Q4 2025 and has held it in 3 quarters since. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • David Shaw held 16,370 shares of Sanara MedTech worth $386K as of Q2 2026.
  • David Shaw bought 47 Sanara MedTech shares in Q2 2026, an estimated $972.
  • Sanara MedTech made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4295 holding.
  • David Shaw first reported a position in Sanara MedTech in Q4 2025 and has held it in 3 quarters since.
  • 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.